Estarylla and Sprintec are the same medication. Both contain exactly 0.25 mg of norgestimate and 35 mcg of ethinyl estradiol, taken as one active pill daily for 21 days followed by 7 inactive pills. They are generic versions of the same original brand-name pill, Ortho-Cyclen, and they work identically to prevent pregnancy.
Why Two Names for the Same Pill
When a brand-name drug’s patent expires, multiple manufacturers can produce their own generic version. Each manufacturer gives their version a unique name, even though the active ingredients and dosages are identical. Estarylla is manufactured by Xiromed, while Sprintec is made by a different company. Beyond those two, there are several other names for the exact same formulation, including Previfem, Mili, and Mono-Linyah. All of them trace back to Ortho-Cyclen as the original reference product.
The key difference between these generics comes down to the inactive ingredients: binders, fillers, dyes, and coatings that hold the pill together and give it its color and shape. These inactive ingredients vary by manufacturer but don’t affect how the drug works. In rare cases, someone may notice a difference in how they tolerate one generic versus another due to a sensitivity to a specific dye or filler, but this is uncommon.
How This Pill Works
Both Estarylla and Sprintec are monophasic combination birth control pills, meaning every active pill in the pack delivers the same dose of hormones. The two active ingredients work together in three ways: they stop the ovaries from releasing an egg each month, thicken cervical mucus to make it harder for sperm to reach an egg, and thin the uterine lining to reduce the chance of implantation.
With perfect use (taking the pill at the same time every day, never missing a dose), about 1 in 100 women will become pregnant over the course of a year. With typical use, which accounts for missed pills and late doses, that number rises to about 5 in 100 women per year.
Common Side Effects
Because the formulation is identical, side effects are the same regardless of whether you’re taking Estarylla or Sprintec. The most frequently reported include headaches, nausea, weight gain, spotting or irregular bleeding between periods, and breast tenderness. Some people also experience fatigue, mood changes, difficulty sleeping, or swelling in the hands and feet. These side effects often improve within the first two to three months as your body adjusts.
More serious but less common reactions include yellowing of the skin or eyes, severe abdominal pain, unusual heavy bleeding lasting more than seven days, or a new breast lump. These warrant immediate medical attention.
Switching Between the Two
If your pharmacy switches you from Sprintec to Estarylla (or the other way around), you don’t need to change anything about how you take your pill. The dosing schedule stays the same, and there’s no gap in protection. Pharmacies commonly substitute one generic for another based on which version they have in stock or which one your insurance covers at a lower copay. You may notice the pill looks different in size, shape, or color, but the medication inside is therapeutically equivalent.
If you’ve been doing well on one version and get switched to the other, there’s no pharmacological reason to expect a change in effectiveness or side effects. If you do notice something feels off after a switch, the inactive ingredients are the most likely explanation, and you can ask your pharmacist whether the original generic is still available.
Why Your Pharmacy Might Pick One Over the Other
The choice between Estarylla and Sprintec almost always comes down to cost and supply chain logistics rather than anything medical. Insurance formularies often prefer one generic over another because of pricing agreements with the manufacturer. If you have a copay difference or your pharmacy is out of stock on one, the swap is straightforward. Both are rated as therapeutically equivalent by the FDA, which means the agency considers them interchangeable without any difference in clinical outcome.